Exact Sciences Cor (EXAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EXAS | AMGN | REGN | VRTX | BMY |
| Company | Exact Sciences Cor | Amgen Inc | Regeneron Pharmaceuticals | Vertex Pharmaceutic | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 67.75 | 322.05 | 1,054.06 | 472.00 | 51.95 |
| High | 68.47 | 322.20 | 1,061.60 | 472.31 | 52.97 |
| Low | 66.39 | 316.92 | 1,040.40 | 461.36 | 51.61 |
| Last | 68.04 | 320.32 | 1,046.91 | 469.76 | 52.90 |
| Change | -0.08 | -1.89 | -4.33 | +4.68 | +1.16 |
| % Change | -0.12% | -0.59% | -0.41% | +1.01% | +2.24% |
| Volume | 1,959,600 | 2,097,300 | 599,300 | 1,128,800 | 17,436,199 |
| 20-Day Average Volume | 2,909,670 | 2,108,665 | 635,445 | 972,565 | 11,996,120 |
| Previous Close | 68.12 | 322.21 | 1,051.24 | 465.08 | 51.74 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 65.76 | 328.05 | 1,114.28 | 471.45 | 49.82 |
| 20-Day Raw Stochastic | 74.43% | 30.21% | 22.14% | 40.17% | 98.71% |
| 20-Day Relative Strength | 60.05% | 45.20% | 36.64% | 47.47% | 65.66% |
| Weighted Alpha | +9.78 | +18.40 | +21.57 | +26.81 | +1.62 |
| Today's Opinion | 88% Buy | 24% Buy | 24% Buy | 8% Buy | 88% Buy |
| Previous Opinion | 88% Buy | 56% Buy | 24% Buy | 8% Buy | 88% Buy |
| Last Month's Opinion | 24% Buy | 96% Buy | 100% Buy | 80% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.00% since 09/24/24 | -3.20% since 09/24/24 | +0.09% since 09/24/24 | +1.46% since 09/24/24 | +3.85% since 09/24/24 |
| Low | 64.85 on 09/26/24 | 312.16 on 09/25/24 | 1,008.41 on 09/25/24 | 458.10 on 09/26/24 | 49.11 on 09/25/24 |
| High | 68.68 on 09/25/24 | 329.50 on 09/25/24 | 1,070.00 on 09/27/24 | 472.31 on 10/01/24 | 52.97 on 10/01/24 |
| 1-Month | |||||
| %Chg | +10.29% since 08/30/24 | -4.05% since 08/30/24 | -11.63% since 08/30/24 | -5.27% since 08/30/24 | +5.91% since 08/30/24 |
| Low | 56.66 on 09/04/24 | 312.16 on 09/25/24 | 1,008.41 on 09/25/24 | 456.07 on 09/24/24 | 47.55 on 09/09/24 |
| High | 71.95 on 09/19/24 | 339.17 on 09/23/24 | 1,192.54 on 09/03/24 | 493.00 on 09/03/24 | 52.97 on 10/01/24 |
| 3-Month | |||||
| %Chg | +60.36% since 07/01/24 | +2.99% since 07/01/24 | -0.96% since 07/01/24 | -0.32% since 07/01/24 | +28.09% since 07/01/24 |
| Low | 41.89 on 07/02/24 | 306.11 on 07/03/24 | 1,008.41 on 09/25/24 | 456.07 on 09/24/24 | 39.35 on 07/05/24 |
| High | 71.95 on 09/19/24 | 346.85 on 07/25/24 | 1,211.20 on 08/27/24 | 510.64 on 08/01/24 | 52.97 on 10/01/24 |
| 6-Month | |||||
| %Chg | -3.37% since 04/01/24 | +13.17% since 04/01/24 | +8.01% since 04/01/24 | +11.72% since 04/01/24 | -0.17% since 04/01/24 |
| Low | 40.62 on 06/25/24 | 260.68 on 04/19/24 | 875.22 on 04/26/24 | 391.01 on 04/18/24 | 39.35 on 07/05/24 |
| High | 79.62 on 04/02/24 | 346.85 on 07/25/24 | 1,211.20 on 08/27/24 | 510.64 on 08/01/24 | 53.35 on 04/02/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 12,570,182 | 172,844,720 | 115,831,920 | 120,015,288 | 104,882,160 |
| Shares Outstanding, K | 184,530 | 536,435 | 110,186 | 258,053 | 2,027,100 |
| Annual Sales | 2,499,770,000 | 28,190,000,000 | 13,117,200,000 | 9,869,200,000 | 45,006,000,000 |
| Annual Net Income | -204,150,000 | 6,717,000,000 | 3,953,600,000 | 3,619,600,000 | 8,025,000,000 |
| Last Quarter Sales | 699,260,000 | 8,388,000,000 | 3,547,100,000 | 2,645,600,000 | 12,201,000,000 |
| Last Quarter Net Income | -15,810,000 | 746,000,000 | 1,432,300,000 | -3,593,600,000 | 1,680,000,000 |
| 60-Month Beta | 1.26 | 0.61 | 0.12 | 0.40 | 0.46 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.09 on 07/31/24 | 4.97 on 08/06/24 | 11.56 on 08/01/24 | -12.83 on 08/01/24 | 2.07 on 07/26/24 |
| Latest Earnings Date | 11/06/24 | 10/30/24 | 10/31/24 | 11/04/24 | 10/31/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | N/A | 0.600 on 07/05/24 |
| Next Ex-Dividends Date | N/A | 08/16/24 | N/A | N/A | 10/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.35 | 27.14 | 0.00 | 37.16 |